Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting

Sexually Transmitted Infections

Volumn 89, Issue 2, 2013, Pages 108-114

  Huang, Wei ^a   Gaydos, Charlotte A ^b   Barnes, Mathilda R ^b   Jett Goheen, Mary ^b   Blake, Diane R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; DOXYCYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECTOPIC PREGNANCY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FEMALE INFERTILITY; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INFERTILITY THERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MONTE CARLO METHOD; NUCLEIC ACID AMPLIFICATION; OUTPATIENT; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; POINT OF CARE TESTING; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; ADULT; CHLAMYDIA TRACHOMATIS; CLINICAL LABORATORY TECHNIQUES; COSTS AND COST ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; LYMPHOGRANULOMA VENEREUM; POINT-OF-CARE SYSTEMS; UNITED STATES; YOUNG ADULT;

EID: 84874636614     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050355     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plans - United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58:362-5.
2. Gift TL, Pate MS, Hook EW III, et al. The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis 1999; 26:232-40.
3. Swain GR, McDonald RA, Pfister JR, et al. Decision analysis: point-of-care Chlamydia testing vs laboratory-based methods. Clin Med Res 2004; 2:29-35.
4. Lau C-Y, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29:497-502.
5. Schwebke JR, Sadler R, Sutton JM, et al. Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic. Sex Transm Dis 1997; 24:181-4.
6. Huppert J, Hesse E, Gaydos CA. What's the point? How point-of-care STI tests can impact infected patients. Point Care 2010; 9:36-46.
7. Hsieh YH, Gaydos CA, Hogan MT, et al. What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing? PLoS One 2011; 6:e19263.
8. Paavonen J, Puolakkainen M, Paukku M, et al. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998; 92:292-8.
9. Blake DR, Maldeis N, Barnes MR, et al. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 2008; 35:649-55.
10. Huang W, Gaydos CA, Barnes MR, et al. Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection. Sex Transm Dis 2011; 38:815-20.
11. Masek BJ, Arora N, Quinn N, et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol 2009; 47:1663-7.
12. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005; 32:725-8.
13. Bachmann LH, Richey CM, Waites K, et al. Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center. Sex Transm Dis 1999; 26:496-9.
14. Hook EW III, Spitters C, Reichart CA, et al. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272:867-70.
15. Geisler WM, Wang C, Morrison SG, et al. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35:119-23.
16. Paavonen J, Kiviat N, Brunham RC, et al. Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol 1985; 152:280-6.
17. Jones RB, Mammel JB, Shepard MK, et al. Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am J Obstet Gynecol 1986; 155:35-9.
18. Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984; 310:545-9.
19. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456-63.
20. Sutton MY, Sternberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005; 32:778-84.
21. Bohm MK, Newman L, Satterwhite CL, et al. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010; 37:131-6.
22. Buchan H, Vessey M, Goldacre M, et al. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol 1993; 100:558-62.
23. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol 2002; 186:929-37.
24. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138(7 Pt 2):880-92.
25. Westrom L, Bengtsson LP, Mardh PA. Incidence, trends, and risks of ectopic pregnancy in a population of women. Br Med J (Clin Res Ed) 1981; 282:15-8.
26. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-92.
27. Chandra A, Stephen EH. Infertility service use among U.S. women: 1995 and 2002. Fertil Steril 2010; 93:725-36.
28. Hirsch MB, Mosher WD. Characteristics of infertile women in the United States and their use of infertility services. Fertil Steril 1987; 47:618-25.
29. Mahilum-Tapay L, Laitila V, Wawrzyniak JJ, et al. New point of care Chlamydia rapid test - bridging the gap between diagnosis and treatment: performance evaluation study. BMJ 2007; 335:1190-4.